Eton Pharmaceuticals (ETON) Cash from Operations (2018 - 2025)
Eton Pharmaceuticals (ETON) posted Cash from Operations of 11551000.0 for Q4 2025, down 196.05% sequentially from 12026000.0 in Q3 2025, and down 1409.93% YoY from 881799.72 in Q4 2024.
Eton Pharmaceuticals (ETON) Cash from Operations (2018 - 2025) Analysis & Trends
Eton Pharmaceuticals has reported Cash from Operations for 8 years, with the latest figure at 11551000.0 in Q4 2025.
- Quarterly Cash from Operations fell 1409.93% year-over-year to 11551000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 10524000.0 (up 986.07% YoY) and the FY2025 annual result came in at 10524000.0, up 986.07% from the prior year.
- Cash from Operations slipped to 11551000.0 in Q4 2025 per ETON's latest filing, from 12026000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 12026000.0 in Q3 2025 and troughed at 11551000.0 in Q4 2025.
- A 5-year average of 920400.0 and a median of 1048000.0 in 2022 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2022 and 2025: Cash from Operations surged 766.94% in 2022, then sank 1409.93% in 2025.
- Over 5 years, Cash from Operations stood at 5117000.0 in 2021, then soared by 155.5% to 2840000.0 in 2022, then tumbled by 86.37% to 387000.0 in 2023, then tumbled by 297.67% to 765000.0 in 2024, then tumbled by 1409.93% to 11551000.0 in 2025.
- According to Business Quant data, Cash from Operations over the past three periods registered 11551000.0, 12026000.0, and 7959000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Eton Pharmaceuticals | 1.67 Bn | 1.64 Bn | 25.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -11.55 Mn |
| Dec 31, 2025 | -11.55 Mn |
| Sep 30, 2025 | 12.03 Mn |
| Sep 30, 2025 | 12.03 Mn |
| Jun 30, 2025 | 7.96 Mn |
| Jun 30, 2025 | 7.96 Mn |
| Mar 31, 2025 | 2.09 Mn |
| Mar 31, 2025 | 2.09 Mn |
| Dec 31, 2024 | -765,000.00 |
| Dec 31, 2024 | -765,000.00 |
| Sep 30, 2024 | 2.95 Mn |
| Sep 30, 2024 | 2.95 Mn |
| Jun 30, 2024 | 1.26 Mn |
| Jun 30, 2024 | 1.26 Mn |
| Mar 31, 2024 | -2.47 Mn |
| Mar 31, 2024 | -2.47 Mn |
| Dec 31, 2023 | 387,000.00 |
| Dec 31, 2023 | 387,000.00 |
| Sep 30, 2023 | 873,000.00 |
| Sep 30, 2023 | 873,000.00 |